|
2 Companies |
|
1 Product |
|
1 Product |
|
5 Mechanisms of Action |
|
0 Trials |
|
54 News |
|
| 12» |
- | Trial completion, Enrollment change: Heparin Versus Saline in Peripheral Venous Catheter (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=354, Completed, Sponsor: Hospital General Universitario Gregorio Mara
Recruiting --> Completed | N=950 --> 354
- | NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light (clinicaltrials.gov) - Oct 30, 2018
P=N/A, N=0, Withdrawn, Sponsor: Ultraviolet Interventions
Recruiting --> Completed | N=950 --> 354 N=10 --> 0 | Recruiting --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: PYCBAC: Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters. (clinicaltrials.gov) - Oct 25, 2018
P=N/A, N=247, Completed, Sponsor: Fundaci
N=10 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=516 --> 247 | Trial completion date: Dec 2016 --> Jul 2017 | Trial primary completion date: Sep 2016 --> Jun 2017
- | Enrollment change, Trial withdrawal: Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome (clinicaltrials.gov) - Jun 22, 2017
P2, N=0, Withdrawn, Sponsor: Boston Children
Recruiting --> Completed | N=516 --> 247 | Trial completion date: Dec 2016 --> Jul 2017 | Trial primary completion date: Sep 2016 --> Jun 2017 N=48 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment open, Trial initiation date, Trial primary completion date: Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=10, Recruiting, Sponsor: Ultraviolet Interventions
N=48 --> 0 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting | Initiation date: Sep 2016 --> Apr 2017 | Trial primary completion date: Jul 2017 --> Apr 2018
- |||| nitroglycerin / Generic mfg.
Trial completion, Trial primary completion date: Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution (clinicaltrials.gov) - Mar 28, 2017
P1/2, N=60, Completed, Sponsor: Novel Anti-Infective Technologies, LLC
Not yet recruiting --> Recruiting | Initiation date: Sep 2016 --> Apr 2017 | Trial primary completion date: Jul 2017 --> Apr 2018 Enrolling by invitation --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016
- ||| Trial completion, Trial initiation date, Trial primary completion date: Influence of Bionecteurs on Catheter-associated Infection (clinicaltrials.gov) - Nov 15, 2016
P=N/A, N=221, Completed, Sponsor: University Hospital Tuebingen
Enrolling by invitation --> Completed | Trial primary completion date: Nov 2016 --> Jun 2016 Recruiting --> Completed | Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: Apr 2016 --> Nov 2015
- New trial: Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light (clinicaltrials.gov) - Sep 14, 2016
P=N/A, N=10, Not yet recruiting, Sponsor: Ultraviolet Interventions
- Cubicin (daptomycin) / Merck (MSD)
Trial primary completion date: Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus (clinicaltrials.gov) - Jul 20, 2016
P2, N=11, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed | Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: Apr 2016 --> Nov 2015 Trial primary completion date: Sep 2012 --> Oct 2007
- Trial completion: ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (clinicaltrials.gov) - Jul 1, 2016
P=N/A, N=162, Completed, Sponsor: Centre Hospitalier R
Trial primary completion date: Sep 2012 --> Oct 2007 Active, not recruiting --> Completed
- minocycline / Generic mfg.
Trial termination, Surgery: Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children (clinicaltrials.gov) - Feb 24, 2016
P4, N=326, Terminated, Sponsor: Indiana University School of Medicine
Active, not recruiting --> Completed Completed --> Terminated; Blinded interim analysis resulted in early termination of the study.
- Trial primary completion date: ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (clinicaltrials.gov) - Feb 22, 2016
P=N/A, N=162, Active, not recruiting, Sponsor: Centre Hospitalier R
Completed --> Terminated; Blinded interim analysis resulted in early termination of the study. Trial primary completion date: Dec 2015 --> May 2016
- Trial completion: Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=150, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed
- Trial completion: Effectiveness of Catheter Reminder and Evaluation Program (clinicaltrials.gov) - Nov 21, 2015
P=N/A, N=874, Completed, Sponsor: Siriraj Hospital
Active, not recruiting --> Completed Recruiting --> Completed
- nitroglycerin / Generic mfg.
Enrollment open: Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution (clinicaltrials.gov) - Nov 21, 2015
P1/2, N=60, Enrolling by invitation, Sponsor: Novel Anti-Infective Technologies, LLC
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- | nitroglycerin / Generic mfg.
New P1/2 trial: Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution (clinicaltrials.gov) - Oct 22, 2015
P1/2, N=60, Not yet recruiting, Sponsor: Novel Anti-Infective Technologies, LLC
- | New P4 trial, HEOR: CITRIM: Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters (clinicaltrials.gov) - Sep 29, 2015
P4, N=179, Completed, Sponsor: Catholic University of Pelotas
- | vancomycin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion, Trial primary completion date: Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections (clinicaltrials.gov) - Sep 25, 2015
P3, N=252, Completed, Sponsor: Rabin Medical Center
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> May 2014
- New trial: PYCBAC: Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters. (clinicaltrials.gov) - Sep 2, 2015
P=N/A, N=516, Recruiting, Sponsor: Fundaci
- Enrollment closed: ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (clinicaltrials.gov) - Aug 28, 2015
P=N/A, N=162, Active, not recruiting, Sponsor: Centre Hospitalier R
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> May 2014 Recruiting --> Active, not recruiting
- Enrollment open, Trial primary completion date: Influence of Bionecteurs on Catheter-associated Infection (clinicaltrials.gov) - Jul 14, 2015
P=N/A, N=200, Recruiting, Sponsor: University Hospital Tuebingen
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
- Enrollment change, Trial withdrawal: ToPICL: Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections (clinicaltrials.gov) - May 29, 2015
P=N/A, N=0, Withdrawn, Sponsor: Fraser Health
Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 N=140 --> 0 | Terminated --> Withdrawn
- Trial withdrawal: Novel Device for Reducing Catheter-Related Infections (clinicaltrials.gov) - May 5, 2015
P=N/A, N=0, Withdrawn, Sponsor: University of Kansas
N=140 --> 0 | Terminated --> Withdrawn Withheld --> Withdrawn
- mupirocin / Generic mfg.
Trial completion: Use of Ointments in Prevention of Catheter Related Infections in PD (clinicaltrials.gov) - Mar 18, 2015
P4, N=200, Completed, Sponsor: University Health Network, Toronto
Withheld --> Withdrawn Active, not recruiting --> Completed
- Trial completion, Enrollment change: Pediatric Ethanol Lock Therapy Study. (clinicaltrials.gov) - Dec 12, 2014
P=N/A, N=15, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=20 --> 15
- Enrollment open: ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=162, Recruiting, Sponsor: Centre Hospitalier R
Enrolling by invitation --> Completed | N=20 --> 15 Not yet recruiting --> Recruiting
- Clinical: ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (clinicaltrials.gov) - Oct 30, 2014
P=N/A, N=162, Not yet recruiting, Sponsor: Centre Hospitalier Régional Metz-Thionville
- Trial completion, Enrollment change: Nissle 1917: Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=50, Completed, Sponsor: Nationwide Children's Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed | N=100 --> 50
- Enrollment change, Trial termination, Trial primary completion date: Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates (clinicaltrials.gov) - Oct 4, 2014
P=N/A, N=10, Terminated, Sponsor: East Carolina University
Recruiting --> Completed | N=100 --> 50 N=150 --> 10 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Jun 2011; Primary investigator relocated
- chlorhexidine gluconate / Generic mfg.
Trial completion: Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=350, Completed, Sponsor: The Methodist Hospital System
N=150 --> 10 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Jun 2011; Primary investigator relocated Active, not recruiting --> Completed
- | vancomycin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment closed: Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections (clinicaltrials.gov) - Jul 15, 2014
P3, N=250, Active, not recruiting, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Prospective Randomized Controlled Multicenter Trial of 4 Antiseptic Strategies for Prevention of Catheter Infection in Intensive Care Unit for Adults Patients (clinicaltrials.gov) - Mar 6, 2014
P4, N=2400, Completed, Sponsor: Poitiers University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Alcohol Locks for the Prevention of Tunneled Catheter-related Infections (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=440, Completed, Sponsor: Erasmus Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=150, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study (clinicaltrials.gov) - Nov 21, 2013
P=N/A, N=40, Completed, Sponsor: University of Manitoba
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Comparison of Infection Rates Among Patients Using Two Catheter Access Devices (clinicaltrials.gov) - Aug 18, 2013
P=N/A, N=10000, Completed, Sponsor: Emory University
Active, not recruiting --> Completed N=7500 --> 10000
- Trial completion: Comparison of Infection Rates Among Patients Using Two Catheter Access Devices (clinicaltrials.gov) - Aug 18, 2013
P=N/A, N=10000, Completed, Sponsor: Emory University
N=7500 --> 10000 Not yet recruiting --> Completed
- chlorhexidine gluconate / Generic mfg.
Enrollment closed: Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit (clinicaltrials.gov) - Jul 9, 2013
P=N/A, N=350, Active, not recruiting, Sponsor: The Methodist Hospital System
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- || New P3 trial: Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients (clinicaltrials.gov) - Mar 27, 2013
P3, N=212, Terminated, Sponsor: Maastricht University Medical Center
- Clinical: Nissle 1917: Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children (clinicaltrials.gov) - Sep 26, 2012
P=N/A, N=100, Recruiting, Sponsor: Nationwide Children's Hospital
- Clinical: Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia (clinicaltrials.gov) - Sep 19, 2012
P=N/A, N=66, Completed, Sponsor: Erasme University Hospital
- | Cubicin (daptomycin) / Merck (MSD)
Enrollment change: Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus (clinicaltrials.gov) - Sep 17, 2012
P2, N=11, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Active, not recruiting N=50 --> 11
- | Cubicin (daptomycin) / Merck (MSD)
Trial completion: Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus (clinicaltrials.gov) - Sep 17, 2012
P2, N=11, Completed, Sponsor: M.D. Anderson Cancer Center
N=50 --> 11 Active, not recruiting --> Completed
- Trial completion: DRESSING2: Impact of Tegaderm HP and CHG in Major Catheter Related Infections and Dressing Detachment (clinicaltrials.gov) - Sep 13, 2012
P4, N=1960, Completed, Sponsor: University Hospital, Grenoble
Active, not recruiting --> Completed Recruiting --> Completed
- Trial termination: Ethanol in the Prevention of Central Venous Catheter Infections (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=200, Terminated, Sponsor: Hospital General Universitario Gregorio Mara
Recruiting --> Completed Recruiting --> Terminated; The non significative reduction of CRBSI adverse events,the need for a high frecuency of catheter manipulations
- Enrollment change: Ethanol in the Prevention of Central Venous Catheter Infections (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=200, Terminated, Sponsor: Hospital General Universitario Gregorio Mara
Recruiting --> Terminated; The non significative reduction of CRBSI adverse events,the need for a high frecuency of catheter manipulations N=950 --> 200
- | New P4 trial: Prospective Randomized Controlled Multicenter Trial of 4 Antiseptic Strategies for Prevention of Catheter Infection in Intensive Care Unit for Adults Patients (clinicaltrials.gov) - Jun 25, 2012
P4, N=2400, Completed, Sponsor: Poitiers University Hospital
- minocycline / Generic mfg.
Enrollment change, Surgery: Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children (clinicaltrials.gov) - Apr 4, 2012
P4, N=326, Completed, Sponsor: Indiana University School of Medicine
N=950 --> 200 N=580 --> 326
- Trial completion: TDPAFD: Fixation of Thoracic Epidurals Influencing Catheter-related Infections and Dislocation (clinicaltrials.gov) - Dec 18, 2011
P=N/A, N=140, Completed, Sponsor: Heinrich-Heine University, Duesseldorf
N=580 --> 326 Recruiting --> Completed
- Enrollment change: Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit (clinicaltrials.gov) - Oct 10, 2011
P=N/A, N=321, Completed, Sponsor: Children's Mercy Hospital Kansas City
Recruiting --> Completed N=218 --> 321